canin
describ
origin
believ
nonpathogen
recent
work
shown
caus
resorpt
abort
pregnant
bitchesan
outcom
report
enteritiscaus
larg
bodi
literatur
avail
genet
structur
differ
close
relat
felin
panleukopenia
viru
fpv
three
four
dna
sequenc
chang
feasibl
could
deriv
flom
fpv
close
relat
parvoviru
rel
small
number
dna
mutat
natur
ancestr
viru
known
acquir
properti
permit
infect
dog
abl
spread
rapidli
preexist
immun
dog
popul
late
serolog
analys
store
serum
sampl
conduct
number
investig
differ
countri
earliest
report
cpv
posit
sera
greec
posit
sera
first
identifi
europ
unit
state
case
diagnos
worldwid
genom
analysi
demonstr
canin
parvoviru
continu
evolv
parrish
et
af
report
isol
examin
singl
type
isol
howev
could
distinguish
reactiv
specif
monoclon
antibodi
restrictionendonucleas
cleavag
pattern
moreov
latter
strain
appar
select
advantag
parent
strain
virtual
replac
mid
parrish
et
al
propos
name
new
strain
indic
subtyp
serum
dog
expos
either
crossreact
virus
vaccin
crossprotect
subsequ
studi
reveal
emerg
third
subtyp
becom
predomin
type
isol
unit
state
small
size
parvoviru
genom
avail
exquisit
sensit
molecular
probe
made
possibl
track
evolut
remark
detail
entir
threedimension
surfac
viru
map
locat
individu
amino
acid
identifi
epidemiolog
initi
outbreak
canin
parvoviru
character
high
morbid
high
mortal
major
dog
group
becom
clinic
ill
outbreak
longer
occur
diseas
encount
almost
exclus
puppi
age
week
month
virtual
adult
dog
immun
either
result
vaccin
natur
infect
immun
canin
parvoviru
follow
infect
modifi
live
vaccin
longlivedmor
year
perhap
lifelong
therefor
pool
suscept
anim
puppi
born
popul
protect
infect
first
week
life
matern
antibodi
diseas
longer
encount
neonat
matern
antibodi
titer
declin
howev
becom
suscept
infect
adequ
immun
becom
infect
first
year
life
canin
parvoviru
persist
long
period
environ
month
ubiquit
endem
parvoviru
cycl
exist
among
wild
canid
larg
breed
coloni
instanc
fatal
diseas
still
encount
subclin
infect
common
especi
adult
evidenc
seroconvers
without
evid
clinic
diseas
clinic
case
practic
gener
milder
better
surviv
rate
decad
ago
possibl
due
part
lower
challeng
dose
initi
larg
number
dog
suscept
amount
viru
environ
amplifi
dog
becam
infect
challeng
dose
increas
time
suscept
dog
becom
infect
nowaday
except
larg
coloni
littl
opportun
stich
amplif
occur
high
level
popul
immun
two
diseas
entiti
associ
infect
initi
describ
enter
myocard
latter
form
virtual
disappear
result
popul
immun
parvovir
myocard
develop
puppi
becom
infect
near
time
birth
myocardi
cell
still
rapidli
prolifer
autonom
parvovirus
includ
replic
divid
cell
virtual
bitch
immun
pass
immun
pup
colostrum
virtual
puppi
refractori
infect
critic
period
infect
myocardium
possibl
result
myocardi
form
diseas
longer
seen
pathogenesi
canin
parvoviru
infect
studi
great
detail
meunier
et
ap
maccartney
et
al
infect
acquir
ingest
infecti
viru
minim
infecti
dose
known
appear
small
perhap
hundr
tissu
cultur
infect
dose
tcid
taken
togeth
enorm
amount
viru
shed
infect
anim
billion
tcid
ofg
fece
hardi
viru
environ
suffici
account
rapid
world
wide
spread
infect
late
ingest
viral
replic
occur
oropharynx
first
day
infect
spread
organ
way
blood
stream
fig
third
fifth
day
viremia
mark
although
usual
manifest
enter
diseas
parvovir
infect
system
viru
reach
intestin
mucosa
blood
stream
rather
intestin
lumen
reason
serum
antibodi
titer
strongli
correl
protect
passiv
deriv
antibodi
complet
protect
suffici
amount
intestin
iga
essenti
protect
clinic
sign
cpv
enter
manifest
day
oral
exposur
incub
period
believ
rang
day
viru
first
shed
day
often
clinic
sign
appear
lesion
result
canin
parvoviru
determin
primarili
autonom
parvovirus
requir
activ
divid
cell
henc
viral
replic
occur
princip
tissu
high
rate
cell
turnoverth
intestin
lymphoid
tissu
bone
marrow
cell
must
also
possess
appropri
viral
receptor
tissu
prolifer
cell
popul
affect
condit
increas
cell
turnov
favor
viral
replic
increas
sever
result
lesion
clinic
diseas
henc
exposur
canin
coronaviru
stimul
prolifer
germin
epithelium
intestin
crypt
destroy
matur
villou
epitheliocyt
preced
canin
parvoviru
infect
result
dual
infect
sever
produc
either
viru
individu
intestin
tract
parvovir
replic
kill
cell
germin
epithelium
intestin
crypt
lead
epitheli
loss
villu
shorten
vomit
diarrhea
lymphoid
necrosi
destruct
myeloprolif
cell
result
lymphopenia
sever
case
panleukopenia
immun
canin
parvoviru
develop
rapidli
circul
antibodi
canin
parvoviru
usual
detect
time
clinic
sign
commenc
peak
rapidli
cours
clinic
ill
rapid
immun
respons
key
determin
sever
clinic
manifest
diseas
anim
abl
limit
magnitud
durat
viremia
milder
diseas
greater
chanc
recoveri
may
explain
kill
vaccin
fail
prevent
infect
nevertheless
appear
protect
dog
clinic
ill
anamnest
respons
infect
suffici
rapid
curtail
viremia
dog
surviv
acut
stage
infect
recoveri
enter
form
usual
rapid
complet
even
fatal
case
evid
intestin
regener
extinct
myocardi
form
lead
chronic
progress
diseas
result
myocardi
damag
immun
longliv
complet
dog
kept
isol
year
rechalleng
complet
refractori
infect
clinic
present
canin
parvoviru
well
knownprodrom
sign
lethargi
inappet
follow
acut
onset
diarrhea
vomit
feveralthough
syndrom
inexplic
unpreced
first
describ
one
observ
lead
link
felin
panleukopenia
observ
profound
leukopenia
sever
affect
dog
case
white
blood
cell
count
low
cellsmm
report
first
case
myocardi
form
diseas
even
perplex
affect
puppi
either
found
dead
die
short
episod
sign
indic
heart
failur
entir
litter
would
affect
die
within
day
wherea
survivor
often
went
develop
chronic
heart
failur
within
month
birth
link
canin
parvoviru
final
made
discoveri
myocardi
cell
nuclei
infect
dog
stain
fluoresc
antibodi
canin
parvoviru
diagnosi
fulmin
case
canin
parvoviru
rel
easi
diseas
dog
caus
constel
acut
enter
fever
leukopenia
less
sever
case
common
classic
textbook
present
pose
diagnost
dilemma
instanc
imposs
differenti
canin
parvovirosi
myriad
caus
acut
enter
dog
basi
clinic
sign
alon
telltal
leukopenia
transient
present
milder
case
may
never
drop
lower
limit
normal
rang
definit
diagnosi
easili
made
demonstr
canin
parvoviru
stool
rel
simpl
task
acut
case
amount
viru
present
number
differ
method
avail
diagnost
laboratoriesvir
isol
stool
hemagglutin
electron
microscopi
forth
perhap
practic
method
practition
inoffic
elisa
test
cite
test
iddexx
portland
cautionari
comment
appli
test
viru
fece
period
fecal
viral
shed
brief
viru
seldom
detect
day
infect
also
modifi
live
canin
parvoviru
vaccin
shed
fece
could
yield
falseposit
result
dog
day
vaccin
support
care
remain
cornerston
therapi
patient
canin
parvoviru
follow
gener
guidelin
manag
acut
enter
anim
present
acuteonset
vomit
diarrhea
triag
manag
outpati
requir
hospit
intens
therapi
patient
minim
vomit
diarrhea
signific
clinic
find
given
support
therapi
sent
home
patient
condit
worsen
fail
respond
support
therapi
within
day
two
anim
hospit
given
complet
workup
intens
therapi
patient
present
acut
vomit
diarrhea
accompani
signific
clinic
sign
high
fever
moder
sever
abdomin
pain
dehydr
blood
diarrhea
vomit
sever
depress
hospit
immedi
patient
need
thorough
diagnost
evalu
intens
therapi
clinic
manag
acut
enter
dog
without
system
sign
includ
dietari
restrict
subcutan
fluid
therapi
case
gastrointestin
medic
patient
reevalu
day
either
offic
visit
telephon
call
owner
dietari
restrict
singl
effect
measur
symptomat
treatment
acut
enter
goal
rest
inflam
gastrointestin
tract
food
withheld
hour
vomit
sever
water
also
withheld
water
withheld
subcutan
fluid
must
given
anim
must
monitor
sign
dehydr
hour
small
amount
warm
bland
diet
offer
commerci
bland
diet
avail
homemad
diet
boil
rice
lowfat
cottag
chees
simpl
prepar
feed
caus
vomit
diarrhea
worsen
food
withheld
addit
hour
tri
small
amount
bland
diet
offer
sever
time
day
next
day
anim
eat
success
gradual
reintroduc
normal
diet
subcutan
fluid
administ
patient
mildli
moder
dehydr
sever
dehydr
anim
need
intraven
fluid
subcutan
fluid
administr
rapid
easi
absorpt
continu
sever
hour
suitabl
outpati
lactat
ringer
solut
supplement
meql
potassium
chlorid
instil
multipl
site
import
give
excess
amount
one
place
result
local
area
necrosi
skin
slough
dog
parvovir
enter
mani
local
act
intestin
prepar
avail
use
year
although
control
scientif
experi
fail
show
benefici
effect
exampl
kaolinpectin
prepar
fail
reduc
either
sever
durat
clinic
sign
human
travel
diarrhea
longer
recommend
gastroenterologist
clinic
trial
human
prepar
contain
bismuth
subsalicyl
reduc
sever
durat
diarrhea
recommend
use
dog
benefit
believ
deriv
princip
subsalicyl
moieti
local
antiprostaglandin
effect
intestin
tract
bismuth
prepar
may
use
help
control
diarrhea
patient
toler
oral
medic
followup
import
often
overlook
aspect
care
acut
enter
owner
contact
hour
first
visit
check
anim
progress
followup
effect
owner
instruct
watch
record
specif
paramet
may
help
prepar
small
chart
complet
list
item
number
bowel
movement
amount
eaten
bodi
temperatur
forth
quickli
review
chart
get
object
assess
whether
anim
condit
get
better
wors
approach
faster
result
better
care
ask
dog
today
anim
brought
clinic
high
fever
sever
depress
bloodi
diarrhea
sign
seriou
diseas
hospit
treat
vigor
fatal
dehydr
irrevers
shock
develop
rapidli
patient
sever
enter
especi
young
puppi
small
bodi
mass
fast
essenti
aspect
treatment
food
withheld
underli
problem
diagnos
treat
anim
clinic
condit
improv
intraven
fluid
therapi
mandatori
sever
dehydr
patient
patient
fluid
loss
vomit
wateri
diarrhea
excess
indwel
intraven
cathet
place
allow
rapid
infus
larg
volum
fluid
anim
may
requir
ideal
fluid
therapi
base
analysi
serum
electrolyt
acidbas
concentr
avail
use
balanc
salt
solut
alon
life
save
initi
fluid
therapi
plan
correct
dehydr
hour
mainten
ml
kg
bodi
weight
suppli
pack
cell
volum
total
solid
bodi
weight
use
monitor
hydrat
continu
water
loss
fece
vomit
may
requir
infus
rate
two
three
time
normal
mainten
requir
routin
use
antibiot
patient
enter
consid
unnecessari
potenti
harm
potenti
lead
bacteri
overgrowth
broadspectrum
parenter
antibiot
recommend
patient
parvovir
enter
howev
disrupt
mucos
barrier
frequenc
secondari
septicemia
antibiot
select
cover
gramposit
gramneg
aerob
anaerob
bacteria
combin
ampicillin
mgkg
gentamicin
mglkg
everi
hour
recommend
veterinarian
care
use
aminoglycosid
antibiot
patient
poor
renal
function
inher
renal
toxic
urin
sediment
monitor
granular
cast
detectedind
onset
tubular
nephrosisth
aminoglycosid
discontinu
oral
antibiot
use
patient
gastroenter
vomit
delay
gastric
empti
impair
peristalsi
alter
intestin
mucosa
occur
gastroenter
make
absorpt
effect
oral
medic
unpredict
unreli
controversi
regard
use
motil
modifi
attempt
control
diarrhea
gastroenterologist
recommend
use
anticholinerg
antidiarrh
medic
suppress
segment
contract
peristalt
contract
may
actual
hasten
transit
time
narcot
analges
synthet
opiat
consid
better
choic
probabl
reserv
sever
prolong
case
howev
slow
flow
intestin
may
increas
toxin
absorpt
evid
canin
parvovir
enter
clinic
sign
due
endotoxin
absorpt
intestin
tract
antiemet
prescrib
sever
case
continu
vomit
make
difficult
maintain
hydrat
electrolyt
balanc
anim
becom
exhaust
metoclopramid
dopamin
antagonist
antiemet
block
chemoreceptor
trigger
zone
increas
tone
caudal
esophag
sphincter
relax
pyloru
duodenum
recommend
dose
mglkg
intramuscularli
subcutan
everi
hour
sever
case
metoclopramid
given
continu
intraven
drip
rate
mgkg
per
hour
period
phenothiazin
deriv
antiemet
block
chemoreceptor
trigger
zone
vomit
center
brain
chlorpromazin
dose
mglkg
intramuscularli
subcutan
everi
hour
prochlorperazin
mgkg
intramuscularli
subcutan
everi
hour
help
control
vomit
without
caus
excess
sedat
phenothiazin
deriv
use
dehydr
patient
howev
block
alphaadrenerg
receptor
caus
arteriolar
vasodil
complic
hypotens
result
dehydr
shock
varieti
vaccin
canin
parvoviru
avail
commerci
sourc
alon
combin
canin
pathogen
effect
administ
seroneg
dog
kill
modifi
live
vaccin
appear
provid
adequ
iinmun
clinic
diseas
appear
dog
immun
kill
vaccin
subclin
infect
within
week
vaccin
subclin
infect
dog
shed
viru
sourc
contagion
anim
princip
challeng
practition
provid
protect
young
puppi
even
endem
coloni
puppi
seroconvert
canin
parvoviru
matern
antibodi
titer
drop
protect
level
week
age
indic
matern
antibodi
suffici
prevent
activ
infect
similarli
puppi
vaccin
matern
antibodi
titer
still
high
evid
activ
immun
respons
unfortun
amount
matern
antibodi
requir
prevent
infect
greater
amount
interfer
vaccin
result
period
sever
day
sever
week
pup
suscept
expos
wildstrain
parvoviru
yet
immuniz
time
durat
critic
period
suscept
affect
two
factor
immun
statu
bitch
natur
vaccin
use
ingest
colostrum
puppi
antibodi
titer
approxim
dam
although
variabl
within
litter
depend
amount
colostrum
ingest
matern
antibodi
declin
fairli
predict
rate
halflif
approxim
day
mean
age
puppi
becom
suscept
infect
respons
vaccin
determin
princip
bitch
antibodi
titer
puppi
bitch
low
titer
may
suscept
earli
week
birth
wherea
puppi
bitch
high
titer
may
refractori
infect
week
fig
differ
amount
antibodi
necessari
protect
minimum
amount
prevent
activ
immun
determin
natur
vaccin
gener
rule
requir
less
matern
antibodi
suppress
respons
kill
vaccin
fig
result
period
suscept
longer
live
vaccin
vari
abil
immun
face
matern
antibodi
gener
figur
effect
matern
antibodi
level
suscept
infect
vaccin
kill
vaccin
two
hypothet
litter
illustr
lower
matern
antibodi
level
requir
suppress
respons
kill
vaccin
compar
modifi
live
vaccin
period
suscept
infect
longer
age
success
immun
occur
later
instanc
data
present
inadequ
substanti
claim
gener
rule
commerci
avail
vaccin
immun
puppi
becom
suscept
infect
result
vaccin
alon
inadequ
break
endem
parvoviru
cycl
infect
coloni
matter
frequent
given
brand
use
likewis
practition
continu
encount
case
parvovir
enter
puppi
receiv
one
sever
inocul
vaccin
case
vaccin
fail
protect
immun
respons
suppress
matern
antibodi
puppi
expos
virul
practic
import
find
regardless
vaccin
use
owner
breeder
must
take
step
minim
potenti
exposur
puppi
cpv
prior
week
age
veterinarian
must
give
seri
inocul
begin
time
first
present
week
age
continu
week
age
veterinarian
must
prepar
explain
owner
even
rigor
vaccin
protocol
complet
elimin
risk
infect
although
singl
success
inocul
need
adequ
immun
anim
imposs
predict
inocul
success
immun
optiin
interv
vaccin
depend
valu
anim
assess
costbenefit
relationship
afford
frequent
vaccin
shorter
interv
increas
probabl
vaccin
puppi
earliest
immuniz
moment
also
increasingli
expens
recognit
subtyp
rais
specter
current
vaccin
inadequ
protect
new
strain
claim
support
experiment
differ
among
variou
subtyp
minor
current
vaccin
crossprotect
known
strain
clear
consensu
matern
antibodi
interfer
account
virtual
suppos
vaccin
failur
canin
parvoviru
truli
new
pathogen
dog
emerg
late
initi
seen
epidem
diseas
dog
parvovir
enter
primarili
diseas
dog
matern
antibodi
interfer
immun
account
vast
major
vaccin
break
molecular
virolog
method
reveal
continu
evolut
viru
appear
greater
academ
practic
interest
clinic
diagnosi
definit
fulmin
case
requir
laboratori
supportusu
demonstr
viru
fecesin
less
clearcut
case
treatment
remain
symptomat
base
simpli
principl
good
support
care
viru
firmli
entrench
wild
domest
canin
popul
elimin
viru
imposs
remain
concern
small
anim
practition
indefinit
